Neumora Therapeutics, Inc. Common StockNMRANASDAQ
Loading
Total value of everything the company owns
3Y CAGR
-9.6%/yr
Annual compound
Percentile
P40
Within normal range
vs 3Y Ago
0.7x
Contraction
Streak
1 yr
Consecutive declineContracting
| Period | Value | YoY Change |
|---|---|---|
| 2024 | $316.97M | -36.1% |
| 2023 | $496.19M | +16.4% |
| 2022 | $426.23M | -0.7% |
| 2021 | $429.30M | +116.9% |
| 2020 | $197.95M | - |
| 2019 | $0.00 | - |